In the latest trading session,, 0.66 million Taysha Gene Therapies Inc (NASDAQ:TSHA) shares changed hands as the company’s beta touched 0.26. With the company’s most recent per share price at $2.79 changed hands at -$0.15 or -5.27% at last look, the market valuation stands at $520.85M. TSHA’s current price is a discount, trading about -39.43% off its 52-week high of $3.89. The share price had its 52-week low at $0.50, which suggests the last value was 82.08% up since then. When we look at Taysha Gene Therapies Inc’s average trading volume, we note the 3-month average coming to 2.76 million.

Taysha Gene Therapies Inc (NASDAQ:TSHA) trade information

Instantly TSHA was in red as seen in intraday trades today. With action 3.92%, the performance over the past five days has been green. The drop to weekly highs of 3.40 subtracted -5.27% to the stock’s daily price. The company’s shares are showing year-to-date upside of 57.34%, with the 5-day performance at 3.92% in the green. However, in the 30-day time frame, Taysha Gene Therapies Inc (NASDAQ:TSHA) is 30.14% up. Looking at the short shares, we see there were N/A shares sold at short interest cover period of N/A days.

Taysha Gene Therapies Inc (TSHA) estimates and forecasts

Data shows that the Taysha Gene Therapies Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 19.53% over the past 6 months, a 59.38% in annual growth rate that is considerably higher than the industry average of 21.60%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -137.69%. The 2024 estimates are for Taysha Gene Therapies Inc earnings to increase by 57.48%.